Detalhe da pesquisa
1.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
N Engl J Med
; 387(1): 9-20, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665782
2.
Glutamine deficiency drives transforming growth factor-ß signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts.
Cancer Sci
; 114(11): 4376-4387, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706357
3.
Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance.
Cancer Sci
; 114(6): 2674-2688, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916999
4.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
N Engl J Med
; 382(7): 610-621, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31825192
5.
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
Jpn J Clin Oncol
; 53(1): 4-15, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398439
6.
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 53(3): 203-211, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484305
7.
Evaluation of a novel medical device for pegfilgrastim administration.
Cancer Sci
; 113(5): 1763-1770, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293085
8.
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
N Engl J Med
; 380(20): 1929-1940, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31091374
9.
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).
Jpn J Clin Oncol
; 52(10): 1124-1133, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750038
10.
Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 52(6): 545-553, 2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296894
11.
Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues.
Breast Cancer Res Treat
; 188(3): 649-659, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934277
12.
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
Invest New Drugs
; 39(1): 217-225, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833136
13.
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.
BMC Cancer
; 21(1): 34, 2021 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33413212
14.
Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.
Oncologist
; 25(2): e223-e230, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043762
15.
Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer.
Breast Cancer Res Treat
; 180(3): 687-694, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32140811
16.
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.
Breast Cancer Res Treat
; 171(3): 675-683, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29971625
17.
Evaluation of oral care to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (Oral Care-BC): randomized controlled phase III trial.
Jpn J Clin Oncol
; 46(9): 879-82, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27365521
18.
Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.
Cancer Sci
; 106(6): 734-739, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25786335
19.
Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications.
Jpn J Clin Oncol
; 45(8): 713-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981620
20.
Contribution of problem-solving skills to fear of recurrence in breast cancer survivors.
Breast Cancer Res Treat
; 145(1): 205-10, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24682677